Question 1

Am I eligible for this trial based on my current health and medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins clinical trial (NCT02135029). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Bococizumab compare to my current cholesterol treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins clinical trial (NCT02135029). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from Bococizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins clinical trial (NCT02135029). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins clinical trial (NCT02135029). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins clinical trial (NCT02135029). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins clinical trial (NCT02135029). Contact the study team or your healthcare provider for specific answers.

What this study is about